Fractures in a nationwide population-based cohort of users of breast cancer hormonal therapy.

about

Fractures in a nationwide population-based cohort of users of breast cancer hormonal therapy.

Item

http://www.wikidata.org/entity/Q47575598

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Fractures in a nationwide popu ...... reast cancer hormonal therapy.

@en

Fractures in a nationwide popu ...... reast cancer hormonal therapy.

@nl

type

Item

label

Fractures in a nationwide popu ...... reast cancer hormonal therapy.

@en

Fractures in a nationwide popu ...... reast cancer hormonal therapy.

@nl

prefLabel

Fractures in a nationwide popu ...... reast cancer hormonal therapy.

@en

Fractures in a nationwide popu ...... reast cancer hormonal therapy.

@nl

P1476

Fractures in a nationwide popu ...... reast cancer hormonal therapy.

@en

P2093

Alicia J Smallwood

http://www.w3.org/2001/XMLSchema#string

Amanda L Kong

http://www.w3.org/2001/XMLSchema#string

Elizabeth C Smith

http://www.w3.org/2001/XMLSchema#string

Joan M Neuner

http://www.w3.org/2001/XMLSchema#string

John A Charlson

http://www.w3.org/2001/XMLSchema#string

Purushottam W Laud

http://www.w3.org/2001/XMLSchema#string

Sailaja Kamaraju

http://www.w3.org/2001/XMLSchema#string

Yushu Shi

http://www.w3.org/2001/XMLSchema#string

P2860

Endocrine therapy use among elderly hormone receptor-positive breast cancer patients enrolled in Medicare Part D

An algorithm for the use of Medicare claims data to identify women with incident breast cancer.

Identification and validation of vertebral compression fractures using administrative claims data.

Risk of myocardial infarction, stroke, and fracture in a cohort of community-based breast cancer patients.

Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer.

Socioeconomic factors associated with adjuvant hormone therapy use in older breast cancer survivors

Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials.

Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years.

Fracture risk and adjuvant hormonal therapy among a population-based cohort of older female breast cancer patients

Assessment of letrozole and tamoxifen alone and in sequence for postmenopausal women with steroid hormone receptor-positive breast cancer: the BIG 1-98 randomised clinical trial at 8·1 years median follow-up.

P2888

s11764-017-0666-4

P31

scholarly article

P356

10.1007/S11764-017-0666-4

http://www.w3.org/2001/XMLSchema#string

P577

2017-12-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29243101

http://www.w3.org/2001/XMLSchema#string